Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - milrinone lactate (unii: 9k8xr81mo8) (milrinone - unii:ju9yax04c7) - 200 ug in 1 ml

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - milrinone 10 mg/10 ml - solution for infusion - 1 mg/ml - milrinone 10 mg - milrinone

Kanada - Inggeris - Health Canada

sanofi-synthelabo canada inc - milrinone (milrinone lactate) - solution - 1mg - milrinone (milrinone lactate) 1mg - cardiotonic agents

Israel - Inggeris - Ministry of Health

propharm ltd - milrinone - solution for injection / infusion - milrinone 1 mg / 1 ml - milrinone - for the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. for the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.in pediatric population milhardt is indicated for the short-term treatment (up to 35 hours) of severe congestive heart failure unresponsive to conventional maintenance therapy (glycosides, diuretics, vasodilators and/or angiotensin converting enzyme (ace) inhibitors), and for the short-term treatment (up to 35 hours) of pediatric patients with acute heart failure, including low output states following cardiac surgery

Afrika Selatan - Inggeris - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - granules - see ingredients - each sachet contains fosfomycin trometamol equivalent to 3 g fosfomycin

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - milrinone - solution for infusion - 1mg/1ml

Singapura - Inggeris - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - milrinone lactate 1.427mg eqv milrinone 1.00mg - injection - 1mg - milrinone lactate 1.427mg eqv milrinone 1.00mg 1mg

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - milrinone, quantity: 1 mg/ml - injection, solution - excipient ingredients: glucose monohydrate; lactic acid; sodium hydroxide; water for injections - primacor injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart patients in intensive care and coronary care units not responding to other therapy (e.g. digoxin, diuretics, vasodilators, including ace inhibitors). the majority of experience with intravenous primacor has been in patients receiving digoxin and diuretics. primacor is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Malta - Inggeris - Medicines Authority

p & d pharmaceuticals limited - milrinone - solution for injection - milrinone 1 mg/ml - cardiac therapy

Malta - Inggeris - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - milrinone - solution for injection - milrinone 1 mg/ml - cardiac therapy